Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Revolution Medicines to Participate in November 2025 Investor Conferences
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
DMC Global Reports Third Quarter Financial Results
-
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
-
ImmuCell Announces Onboarding of New CEO and Related Management Changes
-
Arteris Selected by Altera to Advance Intelligent Computing Across Cloud-to-Edge Applications
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
-
OnKure Therapeutics to Participate in Upcoming Investor Conferences
-
Oportun Delivers Fourth Consecutive Quarter of GAAP Profitability, Increases Full-Year 2025 Adjusted EPS Guidance
-
Postal Realty Trust, Inc. Reports Third Quarter 2025 Results
-
The Tile Shop Reports Third Quarter 2025 Results
-
SuRo Capital Corp. Reports Third Quarter 2025 Financial Results
-
Ultragenyx Reports Third Quarter 2025 Financial Results and Corporate Update
-
Inspirato Reports Q3 Financial and Operating Results
-
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
-
Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended September 30, 2025, Declares Fourth Quarter 2025 Dividend of $0.40 Per Common Share
-
Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights
-
Amwell® Announces Results for Third Quarter 2025
-
Weyco Group, Inc. Declares Special Cash Dividend
-
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2025
-
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
-
Nasdaq Reports October 2025 Volumes
-
Workhorse Group Recommends Shareholders Follow Recommendations of Leading Independent Proxy Advisory Firms to Vote FOR Motiv Transaction Today
-
OrthoPediatrics to Participate in Upcoming Conferences
-
Comscore Reports Third Quarter 2025 Results
-
Kratos to Acquire Israel-Based Orbit Technologies Ltd for $356.3 Million
-
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
-
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
-
Ceribell Reports Third Quarter 2025 Financial Results
-
Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
-
Latham Group, Inc. Reports Third Quarter 2025 Financial Results
-
Astera Labs Announces Financial Results for the Third Quarter of Fiscal Year 2025
-
Bitcoin Depot and GPM Investments Partner to Expand Bitcoin Access Across Convenience Stores Nationwide
-
Announcement Regarding Access to the Plan Company’s Evidence Ahead of the Sanction Hearing
-
Cricut, Inc. Reports Third Quarter 2025 Financial Results
-
First Advantage to Participate in Upcoming Investor Conferences
-
Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call
-
Paylocity Announces First Quarter Fiscal Year 2026 Financial Results
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
-
LiveRamp to Present at the Wells Fargo 9th Annual TMT Summit
-
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
-
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Wildspring by Toll Brothers is Now Open in Leander, Texas
-
Key Tronic Corporation Announces Results for The First Quarter of Fiscal Year 2026
-
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
-
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

